CORBUS PHARMACEUTICALS HLDGS CRBP
COM · Common Stock · CUSIP 21833P103
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNorwood, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $5.95. Options: 1 managers hold calls ($0 notional), 1 hold puts ($0).
Trends to Q1 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 66 |
| Q4 2022 | 64 |
| Q1 2023 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 23 | 25 |
| Q1 2023 | 0 | 62 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $65.0k | $31.0k | 0.48 |
| Q4 2022 | $30.5k | $8.1k | 0.27 |
| Q1 2023 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -4.0m |
| BlackRock Inc. | Sold out | -2.4m |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -986.1k |
| TWO SIGMA INVESTMENTS, LP | Sold out | -570.2k |
| Ikarian Capital, LLC | Sold out | -397.2k |
| STATE STREET CORP | Sold out | -395.5k |
| WELLS FARGO & COMPANY/MN | Sold out | -342.1k |
| FMR LLC | Sold out | -333.4k |
| ACADIAN ASSET MANAGEMENT LLC | Sold out | -287.4k |
| NORTHERN TRUST CORP | Sold out | -207.3k |
Biggest calls
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Biggest puts
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | Unchanged | $00 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Insider purchases and sales in Q1 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 0 | — | — |
| Q1 2022 | 3 | $12.4k | 0 | — | — |
| Q2 2022 | 2 | $6.2k | 0 | — | — |
| Q3 2022 | 3 | — | 0 | — | — |
| Q4 2022 | 0 | — | 0 | — | — |
| Q1 2023 | 0 | — | 0 | — | — |
None reported in Q1 2023.
Holders, Q1 2023
| Manager | Shares | Change |
|---|---|---|
| IFP Advisors, Inc 0.00% of their portfolio | 100 $595 | Reduced -300 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |